Prescription digital therapeutic for all cancer patients
Fosanis believes that the best treatment results can only be achieved by addressing medical and psychological needs of patients. Its Mika platform helps patients by providing personalized digital support from monitoring to personalized coaching.
The company is headquartered in Berlin, Germany.View website
Why we invested in Fosanis
Each cancer patient should be treated in a holistic and personalized way, and the Fosanis DTx platform, Mika, is laser-focused on helping individual patients navigate their individual cancer journey. Digital therapeutics in cancer have enormous potential to help patients as a complement to medical intervention.
Discover how we can help you bring your ambition to life
January 26, 2023
Fosanis Expands to Assist Cancer Patients in Great Britain
May 9, 2022
Debiopharm leads investment round for evidence-based digital cancer therapeutic app Mika to empower cancer patients